Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial †
Titel:
Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial †
Auteur:
Clement, P.M. Gauler, T. Machiels, J.P. Haddad, R.I. Fayette, J. Licitra, L.F. Tahara, M. Cohen, E.E.W. Cupissol, D. Grau, J.J. Guigay, J. Caponigro, F. de Castro Jr, G. de Souza Viana, L. Keilholz, U. del Campo, J.M. Cong, X.J. Ehrnrooth, E. Vermorken, J.B.